FiercePharma  Nov 28  Comment 
NIH, others launch 'historic' HIV trial with vaccines from GSK, Sanofi esagonowsky Mon, 11/28/2016 - 14:30
FiercePharma  Nov 22  Comment 
It's on: With simultaneous FDA nods, Sanofi and Novo to vie for combo-med market tracy Tue, 11/22/2016 - 09:26
newratings.com  Nov 22  Comment 
PARIS (dpa-AFX) - Acorda Therapeutics Inc. (ACOR) has decided to discontinue the development of Dalfampridine for treatment of post-stroke walking difficulties, following disappointing results from its trial, dubbed MILESTONE. Although the study...
newratings.com  Nov 22  Comment 
PARIS (dpa-AFX) - Sanofi announced that the U.S. Food and Drug Administration approved once-daily Soliqua 100/33 (insulin glargine & lixisenatide injection) 100 Units/mL & 33 mcg/mL for the treatment of adults with type 2 diabetes inadequately...
FiercePharma  Nov 21  Comment 
Sanofi, Regeneron rack up Humira-topping data for delayed RA therapy sarilumab chelfand Mon, 11/21/2016 - 02:36
Wall Street Journal  Nov 18  Comment 
Sanofi plans to stop producing a bladder-cancer treatment that was in short supply for several years, saying it hasn’t been able to restore full production at a Toronto manufacturing plant.
FiercePharma  Nov 17  Comment 
Sorry, Praluent: Sanofi, Regeneron's PCSK9 med misses boat on early outcomes data boost tracy Thu, 11/17/2016 - 11:44
The Economic Times  Nov 17  Comment 
As per the pact, the company will provide opportunities of internship or project work to NIPER Kolkata MS/PhD students at manufacturing sites.
The Hindu Business Line  Nov 16  Comment 
The Foreign Investment Promotion Board will take up 11 proposals today, including those of Sanofi Synthelabo lndia and Gland Pharma. Other investment proposals on the table include those of Flag Tel...

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki